Global Adipose Derived Stem Cell Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 112

Published Date: 07 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Adipose tissue stem cells (ASCs), known as multipotent stem cells, are most commonly used in the clinical applications in recent years.

According to our (Global Info Research) latest study, the global Adipose Derived Stem Cell Therapy market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Adipose Derived Stem Cell Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Adipose Derived Stem Cell Therapy market size and forecasts, in consumption value ($ Million), 2018-2029
Global Adipose Derived Stem Cell Therapy market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Adipose Derived Stem Cell Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Adipose Derived Stem Cell Therapy market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Adipose Derived Stem Cell Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Adipose Derived Stem Cell Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AlloCure, Antria, Celgene Corporation, Cellleris and Corestem, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Adipose Derived Stem Cell Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Autologous Stem Cells
    Allogeneic Stem Cells

Market segment by Application
    Therapeutic Application
    Research Application

Market segment by players, this report covers
    AlloCure
    Antria
    Celgene Corporation
    Cellleris
    Corestem
    Cytori Therapeutics
    Intrexon
    Mesoblast
    Pluristem Therapeutics
    Tissue Genesis
    BioRestorative Therapies
    Celltex Therapeutics Corporation
    iXCells Biotechnologies
    Pluristem Therapeutics
    Cyagen
    Lonza

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Adipose Derived Stem Cell Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Adipose Derived Stem Cell Therapy, with revenue, gross margin and global market share of Adipose Derived Stem Cell Therapy from 2018 to 2023.
Chapter 3, the Adipose Derived Stem Cell Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Adipose Derived Stem Cell Therapy market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Adipose Derived Stem Cell Therapy.
Chapter 13, to describe Adipose Derived Stem Cell Therapy research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Adipose Derived Stem Cell Therapy
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Adipose Derived Stem Cell Therapy by Type
        1.3.1 Overview: Global Adipose Derived Stem Cell Therapy Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Adipose Derived Stem Cell Therapy Consumption Value Market Share by Type in 2022
        1.3.3 Autologous Stem Cells
        1.3.4 Allogeneic Stem Cells
    1.4 Global Adipose Derived Stem Cell Therapy Market by Application
        1.4.1 Overview: Global Adipose Derived Stem Cell Therapy Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Therapeutic Application
        1.4.3 Research Application
    1.5 Global Adipose Derived Stem Cell Therapy Market Size & Forecast
    1.6 Global Adipose Derived Stem Cell Therapy Market Size and Forecast by Region
        1.6.1 Global Adipose Derived Stem Cell Therapy Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Adipose Derived Stem Cell Therapy Market Size by Region, (2018-2029)
        1.6.3 North America Adipose Derived Stem Cell Therapy Market Size and Prospect (2018-2029)
        1.6.4 Europe Adipose Derived Stem Cell Therapy Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Adipose Derived Stem Cell Therapy Market Size and Prospect (2018-2029)
        1.6.6 South America Adipose Derived Stem Cell Therapy Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Adipose Derived Stem Cell Therapy Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 AlloCure
        2.1.1 AlloCure Details
        2.1.2 AlloCure Major Business
        2.1.3 AlloCure Adipose Derived Stem Cell Therapy Product and Solutions
        2.1.4 AlloCure Adipose Derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 AlloCure Recent Developments and Future Plans
    2.2 Antria
        2.2.1 Antria Details
        2.2.2 Antria Major Business
        2.2.3 Antria Adipose Derived Stem Cell Therapy Product and Solutions
        2.2.4 Antria Adipose Derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Antria Recent Developments and Future Plans
    2.3 Celgene Corporation
        2.3.1 Celgene Corporation Details
        2.3.2 Celgene Corporation Major Business
        2.3.3 Celgene Corporation Adipose Derived Stem Cell Therapy Product and Solutions
        2.3.4 Celgene Corporation Adipose Derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Celgene Corporation Recent Developments and Future Plans
    2.4 Cellleris
        2.4.1 Cellleris Details
        2.4.2 Cellleris Major Business
        2.4.3 Cellleris Adipose Derived Stem Cell Therapy Product and Solutions
        2.4.4 Cellleris Adipose Derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Cellleris Recent Developments and Future Plans
    2.5 Corestem
        2.5.1 Corestem Details
        2.5.2 Corestem Major Business
        2.5.3 Corestem Adipose Derived Stem Cell Therapy Product and Solutions
        2.5.4 Corestem Adipose Derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Corestem Recent Developments and Future Plans
    2.6 Cytori Therapeutics
        2.6.1 Cytori Therapeutics Details
        2.6.2 Cytori Therapeutics Major Business
        2.6.3 Cytori Therapeutics Adipose Derived Stem Cell Therapy Product and Solutions
        2.6.4 Cytori Therapeutics Adipose Derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Cytori Therapeutics Recent Developments and Future Plans
    2.7 Intrexon
        2.7.1 Intrexon Details
        2.7.2 Intrexon Major Business
        2.7.3 Intrexon Adipose Derived Stem Cell Therapy Product and Solutions
        2.7.4 Intrexon Adipose Derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Intrexon Recent Developments and Future Plans
    2.8 Mesoblast
        2.8.1 Mesoblast Details
        2.8.2 Mesoblast Major Business
        2.8.3 Mesoblast Adipose Derived Stem Cell Therapy Product and Solutions
        2.8.4 Mesoblast Adipose Derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Mesoblast Recent Developments and Future Plans
    2.9 Pluristem Therapeutics
        2.9.1 Pluristem Therapeutics Details
        2.9.2 Pluristem Therapeutics Major Business
        2.9.3 Pluristem Therapeutics Adipose Derived Stem Cell Therapy Product and Solutions
        2.9.4 Pluristem Therapeutics Adipose Derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Pluristem Therapeutics Recent Developments and Future Plans
    2.10 Tissue Genesis
        2.10.1 Tissue Genesis Details
        2.10.2 Tissue Genesis Major Business
        2.10.3 Tissue Genesis Adipose Derived Stem Cell Therapy Product and Solutions
        2.10.4 Tissue Genesis Adipose Derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Tissue Genesis Recent Developments and Future Plans
    2.11 BioRestorative Therapies
        2.11.1 BioRestorative Therapies Details
        2.11.2 BioRestorative Therapies Major Business
        2.11.3 BioRestorative Therapies Adipose Derived Stem Cell Therapy Product and Solutions
        2.11.4 BioRestorative Therapies Adipose Derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 BioRestorative Therapies Recent Developments and Future Plans
    2.12 Celltex Therapeutics Corporation
        2.12.1 Celltex Therapeutics Corporation Details
        2.12.2 Celltex Therapeutics Corporation Major Business
        2.12.3 Celltex Therapeutics Corporation Adipose Derived Stem Cell Therapy Product and Solutions
        2.12.4 Celltex Therapeutics Corporation Adipose Derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Celltex Therapeutics Corporation Recent Developments and Future Plans
    2.13 iXCells Biotechnologies
        2.13.1 iXCells Biotechnologies Details
        2.13.2 iXCells Biotechnologies Major Business
        2.13.3 iXCells Biotechnologies Adipose Derived Stem Cell Therapy Product and Solutions
        2.13.4 iXCells Biotechnologies Adipose Derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 iXCells Biotechnologies Recent Developments and Future Plans
    2.14 Pluristem Therapeutics
        2.14.1 Pluristem Therapeutics Details
        2.14.2 Pluristem Therapeutics Major Business
        2.14.3 Pluristem Therapeutics Adipose Derived Stem Cell Therapy Product and Solutions
        2.14.4 Pluristem Therapeutics Adipose Derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 Pluristem Therapeutics Recent Developments and Future Plans
    2.15 Cyagen
        2.15.1 Cyagen Details
        2.15.2 Cyagen Major Business
        2.15.3 Cyagen Adipose Derived Stem Cell Therapy Product and Solutions
        2.15.4 Cyagen Adipose Derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.15.5 Cyagen Recent Developments and Future Plans
    2.16 Lonza
        2.16.1 Lonza Details
        2.16.2 Lonza Major Business
        2.16.3 Lonza Adipose Derived Stem Cell Therapy Product and Solutions
        2.16.4 Lonza Adipose Derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.16.5 Lonza Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Adipose Derived Stem Cell Therapy Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Adipose Derived Stem Cell Therapy by Company Revenue
        3.2.2 Top 3 Adipose Derived Stem Cell Therapy Players Market Share in 2022
        3.2.3 Top 6 Adipose Derived Stem Cell Therapy Players Market Share in 2022
    3.3 Adipose Derived Stem Cell Therapy Market: Overall Company Footprint Analysis
        3.3.1 Adipose Derived Stem Cell Therapy Market: Region Footprint
        3.3.2 Adipose Derived Stem Cell Therapy Market: Company Product Type Footprint
        3.3.3 Adipose Derived Stem Cell Therapy Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Adipose Derived Stem Cell Therapy Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Adipose Derived Stem Cell Therapy Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Adipose Derived Stem Cell Therapy Consumption Value Market Share by Application (2018-2023)
    5.2 Global Adipose Derived Stem Cell Therapy Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Adipose Derived Stem Cell Therapy Consumption Value by Type (2018-2029)
    6.2 North America Adipose Derived Stem Cell Therapy Consumption Value by Application (2018-2029)
    6.3 North America Adipose Derived Stem Cell Therapy Market Size by Country
        6.3.1 North America Adipose Derived Stem Cell Therapy Consumption Value by Country (2018-2029)
        6.3.2 United States Adipose Derived Stem Cell Therapy Market Size and Forecast (2018-2029)
        6.3.3 Canada Adipose Derived Stem Cell Therapy Market Size and Forecast (2018-2029)
        6.3.4 Mexico Adipose Derived Stem Cell Therapy Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Adipose Derived Stem Cell Therapy Consumption Value by Type (2018-2029)
    7.2 Europe Adipose Derived Stem Cell Therapy Consumption Value by Application (2018-2029)
    7.3 Europe Adipose Derived Stem Cell Therapy Market Size by Country
        7.3.1 Europe Adipose Derived Stem Cell Therapy Consumption Value by Country (2018-2029)
        7.3.2 Germany Adipose Derived Stem Cell Therapy Market Size and Forecast (2018-2029)
        7.3.3 France Adipose Derived Stem Cell Therapy Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Adipose Derived Stem Cell Therapy Market Size and Forecast (2018-2029)
        7.3.5 Russia Adipose Derived Stem Cell Therapy Market Size and Forecast (2018-2029)
        7.3.6 Italy Adipose Derived Stem Cell Therapy Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Adipose Derived Stem Cell Therapy Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Adipose Derived Stem Cell Therapy Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Adipose Derived Stem Cell Therapy Market Size by Region
        8.3.1 Asia-Pacific Adipose Derived Stem Cell Therapy Consumption Value by Region (2018-2029)
        8.3.2 China Adipose Derived Stem Cell Therapy Market Size and Forecast (2018-2029)
        8.3.3 Japan Adipose Derived Stem Cell Therapy Market Size and Forecast (2018-2029)
        8.3.4 South Korea Adipose Derived Stem Cell Therapy Market Size and Forecast (2018-2029)
        8.3.5 India Adipose Derived Stem Cell Therapy Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Adipose Derived Stem Cell Therapy Market Size and Forecast (2018-2029)
        8.3.7 Australia Adipose Derived Stem Cell Therapy Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Adipose Derived Stem Cell Therapy Consumption Value by Type (2018-2029)
    9.2 South America Adipose Derived Stem Cell Therapy Consumption Value by Application (2018-2029)
    9.3 South America Adipose Derived Stem Cell Therapy Market Size by Country
        9.3.1 South America Adipose Derived Stem Cell Therapy Consumption Value by Country (2018-2029)
        9.3.2 Brazil Adipose Derived Stem Cell Therapy Market Size and Forecast (2018-2029)
        9.3.3 Argentina Adipose Derived Stem Cell Therapy Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Adipose Derived Stem Cell Therapy Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Adipose Derived Stem Cell Therapy Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Adipose Derived Stem Cell Therapy Market Size by Country
        10.3.1 Middle East & Africa Adipose Derived Stem Cell Therapy Consumption Value by Country (2018-2029)
        10.3.2 Turkey Adipose Derived Stem Cell Therapy Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Adipose Derived Stem Cell Therapy Market Size and Forecast (2018-2029)
        10.3.4 UAE Adipose Derived Stem Cell Therapy Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Adipose Derived Stem Cell Therapy Market Drivers
    11.2 Adipose Derived Stem Cell Therapy Market Restraints
    11.3 Adipose Derived Stem Cell Therapy Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Adipose Derived Stem Cell Therapy Industry Chain
    12.2 Adipose Derived Stem Cell Therapy Upstream Analysis
    12.3 Adipose Derived Stem Cell Therapy Midstream Analysis
    12.4 Adipose Derived Stem Cell Therapy Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Adipose Derived Stem Cell Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Adipose Derived Stem Cell Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Adipose Derived Stem Cell Therapy Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Adipose Derived Stem Cell Therapy Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. AlloCure Company Information, Head Office, and Major Competitors
    Table 6. AlloCure Major Business
    Table 7. AlloCure Adipose Derived Stem Cell Therapy Product and Solutions
    Table 8. AlloCure Adipose Derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. AlloCure Recent Developments and Future Plans
    Table 10. Antria Company Information, Head Office, and Major Competitors
    Table 11. Antria Major Business
    Table 12. Antria Adipose Derived Stem Cell Therapy Product and Solutions
    Table 13. Antria Adipose Derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Antria Recent Developments and Future Plans
    Table 15. Celgene Corporation Company Information, Head Office, and Major Competitors
    Table 16. Celgene Corporation Major Business
    Table 17. Celgene Corporation Adipose Derived Stem Cell Therapy Product and Solutions
    Table 18. Celgene Corporation Adipose Derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Celgene Corporation Recent Developments and Future Plans
    Table 20. Cellleris Company Information, Head Office, and Major Competitors
    Table 21. Cellleris Major Business
    Table 22. Cellleris Adipose Derived Stem Cell Therapy Product and Solutions
    Table 23. Cellleris Adipose Derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Cellleris Recent Developments and Future Plans
    Table 25. Corestem Company Information, Head Office, and Major Competitors
    Table 26. Corestem Major Business
    Table 27. Corestem Adipose Derived Stem Cell Therapy Product and Solutions
    Table 28. Corestem Adipose Derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Corestem Recent Developments and Future Plans
    Table 30. Cytori Therapeutics Company Information, Head Office, and Major Competitors
    Table 31. Cytori Therapeutics Major Business
    Table 32. Cytori Therapeutics Adipose Derived Stem Cell Therapy Product and Solutions
    Table 33. Cytori Therapeutics Adipose Derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. Cytori Therapeutics Recent Developments and Future Plans
    Table 35. Intrexon Company Information, Head Office, and Major Competitors
    Table 36. Intrexon Major Business
    Table 37. Intrexon Adipose Derived Stem Cell Therapy Product and Solutions
    Table 38. Intrexon Adipose Derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Intrexon Recent Developments and Future Plans
    Table 40. Mesoblast Company Information, Head Office, and Major Competitors
    Table 41. Mesoblast Major Business
    Table 42. Mesoblast Adipose Derived Stem Cell Therapy Product and Solutions
    Table 43. Mesoblast Adipose Derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. Mesoblast Recent Developments and Future Plans
    Table 45. Pluristem Therapeutics Company Information, Head Office, and Major Competitors
    Table 46. Pluristem Therapeutics Major Business
    Table 47. Pluristem Therapeutics Adipose Derived Stem Cell Therapy Product and Solutions
    Table 48. Pluristem Therapeutics Adipose Derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. Pluristem Therapeutics Recent Developments and Future Plans
    Table 50. Tissue Genesis Company Information, Head Office, and Major Competitors
    Table 51. Tissue Genesis Major Business
    Table 52. Tissue Genesis Adipose Derived Stem Cell Therapy Product and Solutions
    Table 53. Tissue Genesis Adipose Derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. Tissue Genesis Recent Developments and Future Plans
    Table 55. BioRestorative Therapies Company Information, Head Office, and Major Competitors
    Table 56. BioRestorative Therapies Major Business
    Table 57. BioRestorative Therapies Adipose Derived Stem Cell Therapy Product and Solutions
    Table 58. BioRestorative Therapies Adipose Derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 59. BioRestorative Therapies Recent Developments and Future Plans
    Table 60. Celltex Therapeutics Corporation Company Information, Head Office, and Major Competitors
    Table 61. Celltex Therapeutics Corporation Major Business
    Table 62. Celltex Therapeutics Corporation Adipose Derived Stem Cell Therapy Product and Solutions
    Table 63. Celltex Therapeutics Corporation Adipose Derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 64. Celltex Therapeutics Corporation Recent Developments and Future Plans
    Table 65. iXCells Biotechnologies Company Information, Head Office, and Major Competitors
    Table 66. iXCells Biotechnologies Major Business
    Table 67. iXCells Biotechnologies Adipose Derived Stem Cell Therapy Product and Solutions
    Table 68. iXCells Biotechnologies Adipose Derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 69. iXCells Biotechnologies Recent Developments and Future Plans
    Table 70. Pluristem Therapeutics Company Information, Head Office, and Major Competitors
    Table 71. Pluristem Therapeutics Major Business
    Table 72. Pluristem Therapeutics Adipose Derived Stem Cell Therapy Product and Solutions
    Table 73. Pluristem Therapeutics Adipose Derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 74. Pluristem Therapeutics Recent Developments and Future Plans
    Table 75. Cyagen Company Information, Head Office, and Major Competitors
    Table 76. Cyagen Major Business
    Table 77. Cyagen Adipose Derived Stem Cell Therapy Product and Solutions
    Table 78. Cyagen Adipose Derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 79. Cyagen Recent Developments and Future Plans
    Table 80. Lonza Company Information, Head Office, and Major Competitors
    Table 81. Lonza Major Business
    Table 82. Lonza Adipose Derived Stem Cell Therapy Product and Solutions
    Table 83. Lonza Adipose Derived Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 84. Lonza Recent Developments and Future Plans
    Table 85. Global Adipose Derived Stem Cell Therapy Revenue (USD Million) by Players (2018-2023)
    Table 86. Global Adipose Derived Stem Cell Therapy Revenue Share by Players (2018-2023)
    Table 87. Breakdown of Adipose Derived Stem Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 88. Market Position of Players in Adipose Derived Stem Cell Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 89. Head Office of Key Adipose Derived Stem Cell Therapy Players
    Table 90. Adipose Derived Stem Cell Therapy Market: Company Product Type Footprint
    Table 91. Adipose Derived Stem Cell Therapy Market: Company Product Application Footprint
    Table 92. Adipose Derived Stem Cell Therapy New Market Entrants and Barriers to Market Entry
    Table 93. Adipose Derived Stem Cell Therapy Mergers, Acquisition, Agreements, and Collaborations
    Table 94. Global Adipose Derived Stem Cell Therapy Consumption Value (USD Million) by Type (2018-2023)
    Table 95. Global Adipose Derived Stem Cell Therapy Consumption Value Share by Type (2018-2023)
    Table 96. Global Adipose Derived Stem Cell Therapy Consumption Value Forecast by Type (2024-2029)
    Table 97. Global Adipose Derived Stem Cell Therapy Consumption Value by Application (2018-2023)
    Table 98. Global Adipose Derived Stem Cell Therapy Consumption Value Forecast by Application (2024-2029)
    Table 99. North America Adipose Derived Stem Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 100. North America Adipose Derived Stem Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 101. North America Adipose Derived Stem Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 102. North America Adipose Derived Stem Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 103. North America Adipose Derived Stem Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
    Table 104. North America Adipose Derived Stem Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
    Table 105. Europe Adipose Derived Stem Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 106. Europe Adipose Derived Stem Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 107. Europe Adipose Derived Stem Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 108. Europe Adipose Derived Stem Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 109. Europe Adipose Derived Stem Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
    Table 110. Europe Adipose Derived Stem Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
    Table 111. Asia-Pacific Adipose Derived Stem Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 112. Asia-Pacific Adipose Derived Stem Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 113. Asia-Pacific Adipose Derived Stem Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 114. Asia-Pacific Adipose Derived Stem Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 115. Asia-Pacific Adipose Derived Stem Cell Therapy Consumption Value by Region (2018-2023) & (USD Million)
    Table 116. Asia-Pacific Adipose Derived Stem Cell Therapy Consumption Value by Region (2024-2029) & (USD Million)
    Table 117. South America Adipose Derived Stem Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 118. South America Adipose Derived Stem Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 119. South America Adipose Derived Stem Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 120. South America Adipose Derived Stem Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 121. South America Adipose Derived Stem Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
    Table 122. South America Adipose Derived Stem Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
    Table 123. Middle East & Africa Adipose Derived Stem Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 124. Middle East & Africa Adipose Derived Stem Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 125. Middle East & Africa Adipose Derived Stem Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 126. Middle East & Africa Adipose Derived Stem Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 127. Middle East & Africa Adipose Derived Stem Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
    Table 128. Middle East & Africa Adipose Derived Stem Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
    Table 129. Adipose Derived Stem Cell Therapy Raw Material
    Table 130. Key Suppliers of Adipose Derived Stem Cell Therapy Raw Materials
List of Figures
    Figure 1. Adipose Derived Stem Cell Therapy Picture
    Figure 2. Global Adipose Derived Stem Cell Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Adipose Derived Stem Cell Therapy Consumption Value Market Share by Type in 2022
    Figure 4. Autologous Stem Cells
    Figure 5. Allogeneic Stem Cells
    Figure 6. Global Adipose Derived Stem Cell Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 7. Adipose Derived Stem Cell Therapy Consumption Value Market Share by Application in 2022
    Figure 8. Therapeutic Application Picture
    Figure 9. Research Application Picture
    Figure 10. Global Adipose Derived Stem Cell Therapy Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 11. Global Adipose Derived Stem Cell Therapy Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 12. Global Market Adipose Derived Stem Cell Therapy Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 13. Global Adipose Derived Stem Cell Therapy Consumption Value Market Share by Region (2018-2029)
    Figure 14. Global Adipose Derived Stem Cell Therapy Consumption Value Market Share by Region in 2022
    Figure 15. North America Adipose Derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 16. Europe Adipose Derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 17. Asia-Pacific Adipose Derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 18. South America Adipose Derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 19. Middle East and Africa Adipose Derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 20. Global Adipose Derived Stem Cell Therapy Revenue Share by Players in 2022
    Figure 21. Adipose Derived Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 22. Global Top 3 Players Adipose Derived Stem Cell Therapy Market Share in 2022
    Figure 23. Global Top 6 Players Adipose Derived Stem Cell Therapy Market Share in 2022
    Figure 24. Global Adipose Derived Stem Cell Therapy Consumption Value Share by Type (2018-2023)
    Figure 25. Global Adipose Derived Stem Cell Therapy Market Share Forecast by Type (2024-2029)
    Figure 26. Global Adipose Derived Stem Cell Therapy Consumption Value Share by Application (2018-2023)
    Figure 27. Global Adipose Derived Stem Cell Therapy Market Share Forecast by Application (2024-2029)
    Figure 28. North America Adipose Derived Stem Cell Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 29. North America Adipose Derived Stem Cell Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 30. North America Adipose Derived Stem Cell Therapy Consumption Value Market Share by Country (2018-2029)
    Figure 31. United States Adipose Derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 32. Canada Adipose Derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 33. Mexico Adipose Derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 34. Europe Adipose Derived Stem Cell Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 35. Europe Adipose Derived Stem Cell Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 36. Europe Adipose Derived Stem Cell Therapy Consumption Value Market Share by Country (2018-2029)
    Figure 37. Germany Adipose Derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 38. France Adipose Derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 39. United Kingdom Adipose Derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 40. Russia Adipose Derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 41. Italy Adipose Derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 42. Asia-Pacific Adipose Derived Stem Cell Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 43. Asia-Pacific Adipose Derived Stem Cell Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 44. Asia-Pacific Adipose Derived Stem Cell Therapy Consumption Value Market Share by Region (2018-2029)
    Figure 45. China Adipose Derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 46. Japan Adipose Derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 47. South Korea Adipose Derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 48. India Adipose Derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 49. Southeast Asia Adipose Derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 50. Australia Adipose Derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 51. South America Adipose Derived Stem Cell Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 52. South America Adipose Derived Stem Cell Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 53. South America Adipose Derived Stem Cell Therapy Consumption Value Market Share by Country (2018-2029)
    Figure 54. Brazil Adipose Derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 55. Argentina Adipose Derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 56. Middle East and Africa Adipose Derived Stem Cell Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 57. Middle East and Africa Adipose Derived Stem Cell Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 58. Middle East and Africa Adipose Derived Stem Cell Therapy Consumption Value Market Share by Country (2018-2029)
    Figure 59. Turkey Adipose Derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 60. Saudi Arabia Adipose Derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 61. UAE Adipose Derived Stem Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 62. Adipose Derived Stem Cell Therapy Market Drivers
    Figure 63. Adipose Derived Stem Cell Therapy Market Restraints
    Figure 64. Adipose Derived Stem Cell Therapy Market Trends
    Figure 65. Porters Five Forces Analysis
    Figure 66. Manufacturing Cost Structure Analysis of Adipose Derived Stem Cell Therapy in 2022
    Figure 67. Manufacturing Process Analysis of Adipose Derived Stem Cell Therapy
    Figure 68. Adipose Derived Stem Cell Therapy Industrial Chain
    Figure 69. Methodology
    Figure 70. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

AlloCure
Antria
Celgene Corporation
Cellleris
Corestem
Cytori Therapeutics
Intrexon
Mesoblast
Pluristem Therapeutics
Tissue Genesis
BioRestorative Therapies
Celltex Therapeutics Corporation
iXCells Biotechnologies
Pluristem Therapeutics
Cyagen
Lonza

Related Reports

Global Adipose Derived Stem Cell Therapy Supply, Demand and Key Producers, 2023-2029

Global Adipose Derived Stem Cell Therapy Supply, Demand and Key Producers, 2023-2029

date 19 Jan 2023

date Pharma & Healthcare

The global Adipose Derived Stem Cell Therapy market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Adipose Derived Stem Cell Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Adipose Derived Stem Cell Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Adipose Derived Stem Cell Therapy market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Adipose Derived Stem Cell Therapy

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>